CHUGAI PHARMACEUTICAL CO., LTD |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,814 JPY | +0.56% |
|
+2.78% | -9.88% |
| 05-23 | Tech stocks lift Japan's Nikkei on boost from Nvidia's robust outlook | RE |
| 05-14 | Japan's Nikkei drifts sideways as more earnings, US CPI awaited | RE |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 1,088B 6.96B 545B | Sales 2025 * | 1,128B 7.21B 565B | Capitalization | 7,921B 50.64B 3,968B |
|---|---|---|---|---|---|
| Net income 2024 * | 345B 2.2B 173B | Net income 2025 * | 365B 2.33B 183B | EV / Sales 2024 * | 6.55 x |
| Net cash position 2024 * | 795B 5.08B 398B | Net cash position 2025 * | 1,017B 6.5B 510B | EV / Sales 2025 * | 6.12 x |
| P/E ratio 2024 * |
22.9
x | P/E ratio 2025 * |
21.6
x | Employees | 7,604 |
| Yield 2024 * |
1.76% | Yield 2025 * |
1.84% | Free-Float | 38.08% |
More Fundamentals
* Assessed data
More news
Latest transcript on Chugai Pharmaceutical Co., Ltd
More recommendations
More press releases
| 1 day | +0.56% | ||
| 1 week | +2.78% | ||
| Current month | +0.69% | ||
| 1 month | -3.43% | ||
| 3 months | -23.79% | ||
| 6 months | -8.02% | ||
| Current year | -9.88% |
1 week
4 572.00
4 872.00
1 month
4 572.005 148.00
Current year
4 572.006 697.00
1 year
3 767.006 697.00
3 years
3 191.006 697.00
5 years
2 296.676 697.00
10 years
902.336 697.00
| Managers | Title | Age | Since |
|---|---|---|---|
Osamu Okuda
CEO | Chief Executive Officer | 61 | 31/03/87 |
Junichi Nezu
CTO | Chief Tech/Sci/R&D Officer | - | - |
Hisafumi Okabe
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Masayuki Oku
BRD | Director/Board Member | 79 | 28/02/15 |
Motoo Ueno
BRD | Director/Board Member | 66 | 31/03/84 |
James H. Sabry
BRD | Director/Board Member | 65 | 28/02/19 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 6.57% | 19 M€ | +12.79% | ||
| 1.87% | 57 M€ | +18.54% | ||
| 1.59% | 4 M€ | +21.24% | ||
| 1.53% | 64,792 M€ | +15.93% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/06/24 | 4,814 | +0.56% | 1 357 100 |
| 04/06/24 | 4,787 | -0.52% | 1,888,600 |
| 03/06/24 | 4,812 | +0.65% | 1,415,700 |
| 31/05/24 | 4,781 | +1.90% | 6,295,300 |
| 30/05/24 | 4,692 | +0.17% | 2,310,000 |
Delayed Quote Japan Exchange, June 05, 2024 at 07:32 am
More quotes
Chugai Pharmaceutical Co. Ltd specializes in the research, development, manufacturing and marketing of drugs especially for cancers (40.8% of net sales), bones and joints diseases treatment (18.4%), and kidney diseases (5.9%).
Net sales are distributed geographically as follows: Japan (74,3%), Switzerland (22,8%) and other (2,9%).
Sector
Pharmaceuticals
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
4,787
JPY
Average target price
5,932
JPY
Spread / Average Target
+23.92%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -9.88% | 50.87B | |
| +41.49% | 750B | |
| +34.11% | 606B | |
| -6.91% | 356B | |
| +17.65% | 326B | |
| +5.61% | 286B | |
| +17.64% | 246B | |
| -3.48% | 213B | |
| +10.82% | 213B | |
| +1.60% | 167B |
- Stock Market
- Equities
- 4519 Stock